Trends News Trends In Small Cell Lung Cancer Incidence And Survival

How New Therapies Are Changing the Game for Small Cell Lung Cancer

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, as well as emerging cell, radiotherapy and combination approaches, during an ... Read More

A Look at the Past, Present, and Future of Small Cell Lung Cancer Treatment

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes. The landscape of small cell lung cancer (SCLC) is undergoing a significant ... Read More

Imdelltra Shows Survival Benefit in Small Cell Lung Cancer

Imdelltra significantly improved progression-free and overall survival compared to chemotherapy in small cell lung cancer patients, with a median overall survival of 13.6 months versus 8.3 months. The ... Read More

Tarlatamab Improves Overall Survival in Small Cell Lung Cancer

Results showed tarlatamab demonstrated statistically significant and clinically meaningful improvement in overall survival vs standard of care therapy. Topline data were announced from a phase 3 trial ... Read More

How AI helps detect lung cancer sooner, improving survival rates

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the chances of patients’ survival. Read More

New drug combo nearly doubles survival for BRAF-mutated lung cancer patients, trial shows

First-line use of encorafenib and binimetinib in BRAF V600E NSCLC recorded a median overall survival of 47.6 months, according to data presented at the ESMO congress. Read More

Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced topline results from the Phase III clinical trial, HARMONi, the first global Phase ... Read More

Lung cancer rising among non-smokers — here's why

Cigarette smoking is by far the biggest risk factor for lung cancer, data shows — but in a surprising turn of events, the most common form of the disease is primarily found in non-smokers. Researchers ... Read More

Lung cancer awareness month: 4 things you should know about the silent killer

Lung cancer is no longer solely a smoker's disease, with air pollution emerging as a significant risk factor affecting non-smokers. Early screening is ... Read More

Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya

Two hundred forty-nine patients diagnosed with NSCLC were included with a median age at diagnosis of 61 (IQR, 52-70) years. Most patients were married (n = 177; 71%) and nonsmokers (n = 177; 71%) with ... Read More